|
|
|
Streamlined Prostate Brachytherapy Treatments |
| |
BK
Medical and Varian Medical Systems Collaborate to Streamline
Prostate Brachytherapy Treatments
Other Topics:
Physician Quality Reporting
Varian Medical Systems
April 30, 2008
Copenhagen, Denmark & Charlottesville, VA -- BK Medical, a
wholly owned subsidiary of Analogic Corporation (NASDAQ:ALOG),
and Varian Medical Systems (NYSE:VAR) today announced a global
collaboration to improve and streamline prostate brachytherapy
procedures through a new, digital interface between BK Medical’s
Pro Focus ultrasound scanner and Varian’s VariSeed 8.0 planning
software. |
| |
|
|
| |
This new digital interface
enables new ways of performing prostate brachytherapy with its
easy-to-use, streamlined workflow capabilities that include
automatic calibration and multiple contouring transfers.
Brachytherapy is an effective and widely used weapon in the
armory of oncologists in the fight against prostate cancer.
"This confirms the commitment of our two companies to pioneer
innovative medical solutions,” says Michael Brock, BK Medical’s
president. “Our market-leading positions give us a unique
opportunity to keep up to date with, and respond to, our
customers’ evolving needs. That BK and Varian can combine their
high-quality products and customer solutions is a clear
advantage for our customers and their patients."
“This interface gives us a much higher quality image transfer
and enables VariSeed to be far more interactive with the
ultrasound unit,” says Hosea Mitchell, head of Varian’s
brachytherapy group. “We are delighted to be working closely
with BK Medical to help our customers deliver treatments more
efficiently.”
These efficiency improvements include improved workflow, as the
image calibration data and contours are sent directly from the
ultrasound to VariSeed so the user does not need to calibrate
the images or re-contour the structures, thereby saving time.
The new interface also offers greater flexibility, as the
urologist or radiation oncologist can zoom in or out on the
ultrasound while using the VariSeed intra-operative module
(Implant View) without losing calibration between the two
systems.
BK Medical and Varian will be co-presenting the new interface at
the upcoming 2008 World Congress of Brachytherapy, May 4 - 6, in
Boston, Mass., followed by the 2008 American Urological
Association meeting, May 17-22, in Orlando, Fla.
Facts about BK Medical
BK Medical ApS, a wholly owned subsidiary of Analogic
Corporation (NASDAQ:ALOG), specializes in the development and
production of diagnostic ultrasound equipment. The company is
recognized as a world leader in developing ultrasound scanners
specially designed for surgery and for the investigation of
urological disorders. The product line also includes scanners
for other applications, such as gynecological examinations,
fetal scanning, and radiology.
BK Medical is represented in 60 countries, with subsidiary sales
companies in the U.S., Belgium, Germany, Italy, Norway, Sweden
and the U.K. An extensive network of distributors connects B-K
Medical with Eastern Europe, the Middle East, Asia and the rest
of the world. The company has about 300 employees, of which
about two-thirds are located in Denmark. For more information,
visit http://www.bkmed.com/.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the
world’s leading manufacturer of medical devices and software for
treating cancer and other medical conditions with radiotherapy,
radiosurgery, proton therapy, and brachytherapy. The company
supplies informatics software for managing comprehensive cancer
clinics, radiotherapy centers and medical oncology practices.
Varian is a premier supplier of tubes and digital detectors for
X-ray imaging in medical, scientific, and industrial
applications and also supplies X-ray imaging products for cargo
screening and industrial inspection. Varian Medical Systems
employs approximately 4,600 people who are located at
manufacturing sites in North America and Europe and in its 60
sales and support offices around the world. For more
information, visit http://www.varian.com/.
Forward Looking Statements
Statements in this press release regarding future business,
events, plans, objectives, expectations, estimates, and other
similar matters, including, but not limited to, statements using
the terms "can" and "expect," constitute forward-looking
statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements
contained in this press release are subject to risks and
uncertainties that could cause actual results to differ
materially from those anticipated, including, but not limited
to, the risks described in the company's Annual Report on Form
10-K and other reports filed from time to time by the Company
with the Securities and Exchange Commission. These
forward-looking statements represent the Company's judgment as
of the date of this press release. The Company assumes no
obligation to update or revise these forward-looking statements
because of new information, future events, or otherwise. |
| |
|
|
| |
|
|
